###begin article-title 0
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human telomerase catalyzes nucleolytic primer cleavage
###end article-title 0
###begin p 1
###xml 95 121 95 121 <email xmlns:xlink="http://www.w3.org/1999/xlink">chantal.autexier@mcgill.ca</email>
To whom correspondence should be addressed. Tel: +1 514 340 8260; Fax: +1 514 340 8295; Email: chantal.autexier@mcgill.ca
###end p 1
###begin p 2
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 610 618 610 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 919 930 919 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 299 305 <span type="species:ncbi:4932">yeasts</span>
###xml 495 500 <span type="species:ncbi:9606">human</span>
###xml 583 589 <span type="species:ncbi:9986">rabbit</span>
###xml 943 948 <span type="species:ncbi:9606">human</span>
###xml 1277 1282 <span type="species:ncbi:9606">human</span>
Telomerase is a reverse transcriptase that uses an integral RNA molecule to add de novo G-rich repeats onto telomeric DNA, or onto nontelomeric DNA generated during chromosome fragmentation and breakage events. A telomerase-mediated DNA substrate cleavage activity has been reported in ciliates and yeasts. Nucleolytic cleavage may serve a proofreading function, enhance processivity or ensure that nontemplate telomerase RNA sequences are not copied into DNA. We identified and characterized a human telomerase-mediated nucleolytic cleavage activity using enzyme reconstituted in a rabbit reticulocyte lysate in vitro transcription/translation system and native enzyme extracted from cells. We found that telomerase catalyzed the removal of nucleotides from DNA substrates including those that can form a mismatch with the RNA template or that contain nontelomeric sequences located 3' to a telomeric sequence. Unlike Tetrahymena telomerase, human telomerase catalyzed the removal of more than one nucleotide (up to 13) from telomeric primers. DNA substrates predicted to align at the 3'-end of the RNA template were not cleaved, consistent with cleavage being dictated by the template 5'-end. We also found some differences in the nuclease activity between RRL-reconstituted human telomerase and native enzyme.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c1">1</xref>
###xml 322 329 322 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c2">2</xref>
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c3">3</xref>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c4">4</xref>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c7">7</xref>
Telomeres form a nucleoprotein complex at the ends of linear eukaryotic chromosomes that serves as a protective cap conferring chromosome stability (1). Telomeric DNA is composed of G-rich repeated sequences (TTAGGG in vertebrates) and is a substrate for the ribonucleoprotein (RNP) enzyme telomerase. Telomerase mediates de novo addition of telomeric TTAGGG DNA repeats onto the 3'-ends of chromosomes allowing the maintenance of telomere length and the long-term proliferation of eukaryotic cells (2,3). In addition to elongating pre-existing telomere tracts, telomerase can also catalyze the synthesis of telomeric DNA onto nontelomeric DNA sequences generated by chromosome fragmentation and breakage events (4-7).
###end p 4
###begin p 5
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c8">8</xref>
###xml 287 295 287 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c9">9</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c10">10</xref>
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c8">8</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c11">11</xref>
###xml 559 567 559 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 635 636 635 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c4">4</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c12">12</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c16">16</xref>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c14">14</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c17">17</xref>
###xml 1151 1153 1151 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c18">18</xref>
###xml 1417 1418 1417 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c4">4</xref>
###xml 1419 1421 1419 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c12">12</xref>
###xml 1422 1424 1422 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c13">13</xref>
###xml 1425 1427 1425 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c16">16</xref>
###xml 1429 1431 1429 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c19">19</xref>
###xml 1432 1434 1432 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c21">21</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 254 260 <span type="species:ncbi:9986">rabbit</span>
###xml 618 623 <span type="species:ncbi:4932">yeast</span>
###xml 628 633 <span type="species:ncbi:9606">human</span>
The human telomerase enzyme is minimally composed of a protein catalytic subunit, the telomerase reverse transcriptase (hTERT), and the telomerase RNA (hTR) that is used as a template for telomeric DNA synthesis (8). The expression of hTERT and hTR in a rabbit reticulocyte lysate (RRL) in vitro transcription/translation system is sufficient to reconstitute enzyme activity (9,10). hTR contains a short template sequence of 11 nucleotides complementary to the telomeric repeats (8,11). Telomerase elongation and substrate specificity have been characterized in vitro for a wide range of organisms including protozoa, yeast and human (4,12-16). Short single-stranded oligonucleotides containing bases complementary to the template region can serve as telomerase substrates in a DNA primer extension (conventional) assay (14,17). During telomere repeat synthesis, the 3'-end of the DNA substrate anneals to the telomerase RNA template. Nucleotides are added to the DNA until the 5' terminus of the template sequence is reached; subsequently, the newly synthesized 3'-end of the substrate is repositioned at the beginning (3' terminus) of the template (18). Repeat addition processivity, defined as successive rounds of nucleotide addition and primer translocation, is a key feature of most telomerase enzymes. The 5'-end of the substrate is also thought to bind an anchor site contributing to telomerase processivity (4,12,13,16, 19-21).
###end p 5
###begin p 6
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c22">22</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c23">23</xref>
###xml 147 163 147 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Euplotes crassus</italic>
###xml 165 188 165 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena thermophila</italic>
###xml 190 215 190 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe</italic>
###xml 220 244 220 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c24">24</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c27">27</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c27">27</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c28">28</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c29">29</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c30">30</xref>
###xml 848 859 848 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c31">31</xref>
###xml 1206 1208 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 1209 1211 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 1212 1214 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c27">27</xref>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c28">28</xref>
###xml 1223 1232 1223 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.crassus</italic>
###xml 1350 1352 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 1353 1355 1353 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c28">28</xref>
###xml 147 163 <span type="species:ncbi:5936">Euplotes crassus</span>
###xml 165 188 <span type="species:ncbi:5911">Tetrahymena thermophila</span>
###xml 190 215 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 220 244 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 1223 1232 <span type="species:ncbi:5936">E.crassus</span>
Like a number of DNA and RNA polymerases, telomerase exhibits a DNA substrate cleavage activity in addition to its polymerase function (22,23). In Euplotes crassus, Tetrahymena thermophila, Schizosaccharomyces pombe and Saccharomyces cerevisiae, telomerase cleaves DNA substrates bound via the template sequence of the telomerase RNA (20,24-27) and the cleavage can occur by an endonucleolytic mechanism (25,27). There is some evidence that this cleavage activity is inherent to telomerase. Nuclease activity remains associated with the telomerase complex after extensive purification (28). Cleavage patterns are also altered in specific ways when the telomerase enzyme contains a telomerase RNA mutated in the template sequence (29). RNA sequences outside the template can also influence telomerase cleavage activity (30). Moreover, expression of Tetrahymena TERT and TR in RRL is sufficient to reconstitute cleavage activity (31). Several primers have been tested and reported to be substrates for cleavage. Primers containing bases that can form mismatches with the RNA template sequence are cleaved; cleavage occurs preferentially at the junction of match-mismatch between the primer and the template (20,25,27,28). In E.crassus, telomerase can also remove 3'-terminal nontelomeric DNA from a primer to expose telomeric sequences for elongation (25,28).
###end p 6
###begin p 7
###xml 138 143 <span type="species:ncbi:9606">human</span>
###xml 796 801 <span type="species:ncbi:9606">human</span>
The nucleolytic cleavage activity of vertebrate telomerase has not been characterized. In this study, we report the characterization of a human telomerase-mediated nucleolytic cleavage activity using enzyme reconstituted in RRL and native enzyme extracted from cells. We demonstrated that telomerase catalyzes the removal of 1 to 13 nucleotides from telomeric substrates that can align at, or beyond, the 5'-end of the RNA template sequence, that can form a mismatch with the RNA template, or that contain nontelomeric sequences located 3' to a telomeric sequence. DNA substrates predicted to align at the 3'-end of the RNA template are not cleaved, consistent with cleavage being dictated by the template 5'-end. We also found some differences in the nuclease activity between RRL-reconstituted human telomerase and native enzyme partially purified from 293 cells.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
Oligonucleotides
###end title 9
###begin p 10
###xml 316 318 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
Gel-purified 5'-biotinylated oligonucleotides were obtained from Operon (Alameda, CA) and resuspended in water. To generate the radiolabeled size markers carrying a 3'-terminal dideoxynucleotide, 5'-biotinylated oligonucleotides were 3'-end labeled using terminal deoxynucleotidyltransferase (Invitrogen) and [alpha-32P]dATP (cordycepin: NEN Life Science Products) for 30 min at 37degreesC, followed by DNA precipitation. The modification 'revdT' is a non-nucleosidic group linked at the 3' terminus of the oligonucleotide that blocks any polymerase extension (Operon).
###end p 10
###begin title 11
Plasmid constructions
###end title 11
###begin p 12
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c32">32</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c33">33</xref>
The construction of the pET28b-hTERT and phTR+1 expression plasmids has been described previously (32,33).
###end p 12
###begin title 13
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
In vitro transcription/translation
###end title 13
###begin p 14
###xml 8 16 8 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c17">17</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c34">34</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c34">34</xref>
The RRL in vitro T7-coupled transcription/translation system (Promega) was used as described previously (17,34). Full length hTERT was synthesized in RRL in the presence of purified hTR. hTR was synthesized and purified on RNeasy spin columns (Qiagen) from FspI-linearized phTR+1 plasmid (34).
###end p 14
###begin title 15
DNA primer extension assay
###end title 15
###begin p 16
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c14">14</xref>
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c17">17</xref>
###xml 328 330 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c17">17</xref>
A non-PCR-based telomerase elongation assay was performed (14,17). hTERT protein expressed in 20 microl RRL in the presence of hTR was assayed for telomerase activity in a 40 microl final volume reaction using a gel-purified 5'-biotinylated oligonucleotide (Operon). Standard reaction conditions have been described previously (17). The proteinase K solution was 10 mM Tris-HCl pH 7.5, 0.5% SDS, 0.3 mg/ml proteinase K. The elongation products immobilized on magnetic beads were washed twice with buffer A (10 mM Tris-HCl pH 7.5, 1 M NaCl, 0.5 mM EDTA), once with buffer B (10 mM Tris-HCl pH 7.5) and analyzed by 8 or 10% polyacrylamide- urea gel electrophoresis. The relative amount of cleavage-derived products, expressed by the ratio of cleavage products/elongation products, was determined by densitometric analysis of the autoradiographs (ImageQuant software, Molecular Dynamics). The total counts for each signal were normalized to the amount of transcripts by dividing each product signal by the number of dGTPs it contains. The ratio was calculated using the normalized signals of the major elongation products above the input primer and the major cleavage products below the input primer.
###end p 16
###begin title 17
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human telomerase extracts
###end title 17
###begin p 18
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c32">32</xref>
The preparation of partially purified 293 cell extracts has been described previously (32). DNA primer extension assays were performed with 20 microg of this cellular extract as described above.
###end p 18
###begin title 19
RESULTS
###end title 19
###begin title 20
3'-end cleavage of telomeric DNA substrates
###end title 20
###begin p 21
###xml 81 92 81 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 129 137 129 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c31">31</xref>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 850 851 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c17">17</xref>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c35">35</xref>
###xml 1001 1002 1001 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 405 410 <span type="species:ncbi:9606">human</span>
###xml 485 490 <span type="species:ncbi:9606">human</span>
###xml 708 713 <span type="species:ncbi:9606">human</span>
Nucleolytic cleavage of DNA primer substrates can be reconstituted by expressing Tetrahymena TERT in the presence of TR in a RRL in vitro transcription/translation system, and detected using a DNA primer extension (conventional) assay (31). This result suggests that the DNA cleavage may be dependent on the minimal components required for telomerase activity, TERT and TR. To identify and characterize a human telomerase-mediated nucleolytic cleavage activity, we first reconstituted human telomerase in RRL by expressing hTERT in the presence of hTR, and performed a DNA primer extension assay using different 5'-biotinylated telomeric oligonucleotides (Fig. 1C). As previously reported, RRL-reconstituted human telomerase assayed by the primer extension method generates a ladder of elongation products with a six nucleotide pausing pattern (Fig. 1C, lanes 1, 2) (17,35). Processive elongation of DNA primers by the telomerase enzyme is observed as the addition of multiple telomeric repeats (Fig. 1C, lanes 1, 2).
###end p 21
###begin p 22
###xml 4 15 4 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Euplotes</italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 268 269 268 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 271 272 271 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 273 274 273 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 281 282 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 284 285 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 286 287 286 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 316 317 316 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 318 319 318 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 322 323 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 330 331 330 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 332 333 332 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 336 337 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 338 339 338 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 340 341 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 342 343 342 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 385 396 385 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 421 422 421 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 423 424 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 427 428 427 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 429 430 429 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 431 432 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 433 434 433 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 808 810 804 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 929 930 925 926 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 932 933 928 929 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 934 935 930 931 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 977 978 973 974 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 980 981 976 977 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 982 983 978 979 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1115 1117 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c17">17</xref>
###xml 1507 1508 1503 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 1568 1569 1564 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 1038 1043 <span type="species:ncbi:9606">human</span>
The Tetrahymena and Euplotes telomerase enzymes generate products that are shorter than the original oligonucleotide substrates, detectable as radiolabeled products that migrate below the input primers (20,25). We first assayed telomeric oligonucleotide substrates [(T2AG3)3 and (T2AG3)4], and two others primers [(G2T2AG)4 and (G2T2AG)3G2T2A2G] that mimic oligonucleotides cleaved by Tetrahymena telomerase (Fig. 1D). (G2T2AG)3G2T2A2G is predicted to form a mismatch with the RNA template (Fig. 1B). Under standard reaction conditions, we observed radiolabeled primer-sized products or products below the input primers (Fig. 1C, lanes 1, 2, 6, 7 and Fig. 1D, lanes 1, 4, 7, 10). This product profile results from the removal of one or several terminal primer nucleotides followed by incorporation of [alpha-32P]dGTP during elongation by the telomerase enzyme. These short products were not visualized when 5'-end radiolabeled (T2AG3)3 or 3'-end radiolabeled 5'-biotinylated (T2AG3)3 primers were added to RRL reactions in the absence of human telomerase components, even in the presence of dNTPs (data not shown) (17). These radiolabeled primers were neither cleaved nor elongated. These observations suggest that short products are not generated by random nucleases that might be present in the lysate, and are consistent with cleavage being a telomerase-mediated process. Both telomerase elongation activity and the generation of products shorter than the input primer were hTERT and hTR dependent (Fig. 1C, lanes 3-5), and RNase A and proteinase K sensitive (Fig. 1C, lanes 8-11).
###end p 22
###begin p 23
###xml 73 74 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 76 77 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 78 79 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 591 592 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 682 683 682 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 685 686 685 686 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 687 688 687 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 942 943 942 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 1121 1123 1117 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1136 1137 1132 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 1315 1316 1311 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 1448 1450 1440 1442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1463 1464 1455 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 1574 1575 1566 1567 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1577 1578 1569 1570 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1579 1580 1571 1572 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1737 1738 1729 1730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
The first major product generated by telomerase-mediated elongation of (T2AG3)4 is expected to be 28 nucleotides (nt) in length [primer(P)+4] (Fig. 1A). This product results from enzyme pausing or dissociation upon reaching the 5'-end of the RNA template (Fig. 1A and D, lane 4). Interestingly, telomerase reactions with this primer also led to the formation of cleavage-derived products 16 and 22 nt in length due to the removal of 9 and 3 nt, respectively (Fig. 1B and D, lane 4). The length of shorter products suggested that cleavage occurred 3' to the A residue within the primer (Fig. 1B). To characterize the short products and identify the position of the cleavage within (T2AG3)4, DNA primer extension reactions were performed in the presence of the chain terminators ddATP or ddTTP. Substitutions of dATP with ddATP or TTP with ddTTP in the conventional assays generated specific chain termination products of different sizes (Fig. 1B and D, lanes 5, 6). In the absence of cleavage, chain termination products would be undetectable since the incorporation of ddATP or ddTTP prevents the incorporation of [alpha-32P]dGTP (Fig. 1A). Therefore the chain termination products we detected were generated by cleavage followed by subsequent addition of radiolabeled dGTP and ddATP or ddTTP onto the primer (Fig. 1B). These reactions also generated cleavage-derived products 16 and 22 nt in length resulting only from the incorporation of [alpha-32P]dGTP (Fig. 1D, lanes 5, 6). The results of this experiment indicated that 3 or 9 nt could be cleaved from the 3'-end of (T2AG3)4 depending on the potential alignments of this oligonucleotide with the RNA template, including alignment of the primer beyond the RNA template 5'-end (Fig. 1B).
###end p 23
###begin p 24
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 77 78 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 79 80 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 85 86 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 147 148 147 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 152 153 152 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 459 461 455 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 528 529 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 535 536 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 690 691 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 724 725 720 721 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 726 727 722 723 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 730 731 726 727 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 737 738 733 734 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 739 740 735 736 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 743 744 739 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 745 746 741 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 747 748 743 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 749 750 745 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 882 883 878 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 1010 1011 1006 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 1099 1100 1095 1096 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1101 1102 1097 1098 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1105 1106 1101 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1112 1113 1108 1109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1114 1115 1110 1111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1118 1119 1114 1115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1120 1121 1116 1117 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1122 1123 1118 1119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1124 1125 1120 1121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1216 1217 1212 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 1271 1272 1267 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 1401 1403 1393 1395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1416 1417 1408 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 1602 1603 1594 1595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
Primer extension reactions were also performed with (T2AG3)3, (G2T2AG)4 or (G2T2AG)3G2T2A2G (Fig. 1D, lanes 1-3, 7-12). Reactions conducted with (T2AG3)3 generated cleavage-derived products 16 nt in length consistent with the removal of 3 nt from the 3'-end of the primer (Fig. 1B and D, lane 1). Substitutions of dATP with ddATP or TTP with ddTTP generated chain termination products of 21 or 19 nt, respectively, consistent with the incorporation of [alpha-32P]dGTP subsequent to cleavage and prior to chain termination (Fig. 1B and 1D, lanes 2, 3). These reactions also generated cleavage-derived products 16 nt in length resulting only from the incorporation of radiolabeled dGTP (Fig. 1D, lanes 2, 3). Reactions with (G2T2AG)4 or (G2T2AG)3G2T2A2G (which forms a mismatch with the RNA template) generated cleavage-derived products 24 (primer-size), 18 and 12 nt in length (Fig. 1D, lanes 7, 10), consistent with the cleavage of 1, 7 or 13 nt, depending on the primer alignments with the RNA template (Fig. 1B). Substitutions of dATP with ddATP or TTP with ddTTP in the telomerase assays using (G2T2AG)4 or (G2T2AG)3G2T2A2G as substrates generated chain termination products of 29, 23 and 17 nt (with ddATP: Fig. 1D, lanes 8, 11) or 27, 21 and 15 nt (with ddTTP: Fig. 1D, lanes 9, 12), as well as cleavage-derived products 24, 18 and 12 nt in length resulting only from the incorporation of [alpha-32P]dGTP (Fig. 1D, lanes 8, 9, 11, 12). The length of cleavage-derived and chain termination products suggests that cleavage occurred 3' to the TTA residues within the telomeric sequence primers (Fig. 1B).
###end p 24
###begin title 25
Effects of different reaction conditions on telomerase-mediated primer cleavage
###end title 25
###begin p 26
###xml 20 31 20 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Euplotes</italic>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c14">14</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c27">27</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c31">31</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c36">36</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c37">37</xref>
###xml 750 751 746 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f2">2</xref>
###xml 821 822 817 818 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 824 825 820 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 826 827 822 823 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 43 48 <span type="species:ncbi:4932">yeast</span>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 461 466 <span type="species:ncbi:9606">human</span>
Previous studies in Tetrahymena, Euplotes, yeast and human have shown that an increase in either dGTP or primer concentration in the telomerase assay affects the nucleolytic primer cleavage activity as well as the processivity of the telomerase enzyme (14,27,31,36,37). To determine whether the extent of cleavage is affected by these reaction conditions, we varied either the concentration of dGTP or primer in the telomerase reactions using RRL-reconstituted human telomerase. Unlabeled dGTP was used to increase the total concentration of dGTP from 1.25 to 13.75 microM, which did not affect the relative amount of cleavage-derived products, but promoted the generation of longer products, consistent with an increase in enzyme processivity (Fig. 2A). A similar increase in processivity also occurred by varying the (T2AG3)4 concentration from 0.25 to 5 microM, but the relative amount of cleavage-derived products was also not affected (data not shown).
###end p 26
###begin p 27
###xml 301 302 301 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 304 305 304 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 306 307 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 526 527 526 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 529 530 529 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 531 532 531 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
We speculated that cleavage could be due to pyrophosphorolysis. This reaction can occur when the base at the 3' terminus of a DNA chain reacts with pyrophosphate ions in solution to generate a free dNTP molecule and a DNA chain that is one base shorter. As we observed the removal of 3 or 9 nt from (T2AG3)4, the cleavage activity we have described is not likely to be due to pyrophosphorolysis. Moreover, the addition of 5 U of pyrophosphatase, an enzyme used to inhibit pyrophosphorolysis, did not abolish the cleavage of (T2AG3)3 (data not shown).
###end p 27
###begin p 28
###xml 155 156 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 158 159 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 160 161 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 328 329 328 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 331 332 331 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 333 334 333 334 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f2">2</xref>
To further characterize the cleavage reaction, we assayed a telomeric oligonucleotide substrate containing a modification that prevents chain extension [(T2AG3)3revdT]. This oligonucleotide can only be elongated by the telomerase enzyme if the chain terminating modification is removed. Primer extension assays performed with (T2AG3)3revdT in the presence of either dNTPs or ddNTPs generated cleavage-derived products 16 nt in length, consistent with the removal of 3 nt prior to elongation (Fig. 2B, lanes 6-8).
###end p 28
###begin title 29
Telomerase-mediated primer cleavage is specified by primer alignments with the hTR template sequence
###end title 29
###begin p 30
###xml 3 14 3 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 19 27 19 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Euplotes</italic>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c28">28</xref>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 315 316 315 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 317 318 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 321 322 321 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 323 324 323 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 325 326 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 327 328 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 540 542 536 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 576 577 572 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 774 782 770 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Euplotes</italic>
###xml 795 797 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 798 800 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c28">28</xref>
###xml 898 906 894 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Euplotes</italic>
###xml 1082 1083 1078 1079 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 1083 1084 1079 1080 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1084 1085 1080 1081 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 1085 1086 1081 1082 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1086 1087 1082 1083 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 1106 1107 1102 1103 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 1107 1108 1103 1104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1108 1109 1104 1105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 1109 1110 1105 1106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1110 1111 1106 1107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 1140 1141 1136 1137 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1142 1143 1138 1139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1139 1144 1135 1140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G<sub>3</sub>T<sub>2</sub>A</bold>
###xml 1156 1157 1152 1153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1158 1159 1154 1155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1155 1160 1151 1156 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G<sub>3</sub>T<sub>2</sub>A</bold>
###xml 1309 1310 1305 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 1354 1355 1350 1351 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1356 1357 1352 1353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1353 1358 1349 1354 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G<sub>3</sub>T<sub>2</sub>A</bold>
###xml 1369 1370 1365 1366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1371 1372 1367 1368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1368 1373 1364 1369 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G<sub>3</sub>T<sub>2</sub>A</bold>
###xml 1486 1487 1482 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 1833 1834 1829 1830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 1027 1032 <span type="species:ncbi:9606">human</span>
In Tetrahymena and Euplotes, primer-RNA template interactions regulate telomerase-mediated nucleolytic cleavage activity (20,25,28). In general, mismatches between the primer and the RNA template sequence promote primer cleavage at the junction of match-mismatch. As previously described in Figure 1, cleavage of (G2T2AG)3G2T2A2G, a primer which can form a mismatch with the RNA template, produced products 24 nt in length. Such products would be generated by the removal of the last two 3' nucleotides prior to the incorporation of [alpha-32P]dGTP during DNA synthesis (Fig. 1D, lane 10). Moreover, certain primers containing nontelomeric sequences that are predicted to form mismatches with the RNA template are also good cleavage and subsequent elongation substrates for Euplotes telomerase (25,28). These primers consist of an internal telomeric cassette flanked by nontelomeric DNA sequences. Euplotes telomerase can remove the 3' nontelomeric sequences to expose the telomeric sequences for elongation. RRL-reconstituted human telomerase was assayed using primers [CACTATCGAC-G3T2A-CAT] and [CACTATC-G3T2A-GATCAT] abbreviated as (10-G3T2A-3) and (7-G3T2A-6), respectively (the telomeric cassettes are indicated in bold). These primers are predicted to align with the RNA template as indicated in Figure 3A. Telomerase reactions performed with (10-G3T2A-3) or (7-G3T2A-6) led to the formation of products that were shorter than the input primer at 17 and 14 nt, respectively (Fig. 3B, lanes 2, 3). Product size was consistent with primer cleavage occurring 3' to the telomeric cassette to remove the 3' nontelomeric sequences (3 or 6 nt). Substitutions of dATP with ddATP or TTP with ddTTP in telomerase assays confirmed that 3 or 6 nt were removed, eliminating the nontelomeric DNA before the initiation of DNA synthesis (Fig. 3A and data not shown).
###end p 30
###begin p 31
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 240 251 240 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 282 283 282 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 545 546 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 711 712 709 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 768 779 766 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 817 818 815 816 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 870 871 868 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 912 914 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 342 347 <span type="species:ncbi:9606">human</span>
To determine whether nucleolytic cleavage activity is dictated by the alignment of the primer substrate at the 5'-end of the RNA template, we tested an oligonucleotide [(TG)8TAG] that mimics a primer predicted to align at the 3'-end of the Tetrahymena telomerase RNA template (Fig. 3A) (20). Primer extension reactions with RRL-reconstituted human telomerase did not generate primer-sized products (19 nt) or products below the input primer, but favored the direct extension pathway leading to the formation of products >/=20 nt in length (Fig. 3B, lanes 5-7). This primer generated a six nucleotide pausing pattern starting at 25 nt as expected if it is aligned with the template RNA 3'-end 3'-(A)AUC-5' (Fig. 3A). These results are comparable to those obtained with Tetrahymena telomerase and a similar primer [(TG)8TTG], supporting the predicted alignment of the (TG)8TAG with the 3'-end of the RNA template (20).
###end p 31
###begin p 32
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f1">1</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 152 160 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Euplotes</italic>
###xml 162 169 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c7">7</xref>
###xml 441 442 441 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 443 444 443 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 446 447 446 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 611 612 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 730 731 728 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 732 733 730 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 735 736 733 734 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 827 828 825 826 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 830 831 828 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 832 833 830 831 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 840 841 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 1068 1069 1066 1067 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1070 1071 1068 1069 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1073 1074 1071 1072 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1103 1104 1101 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 1237 1238 1235 1236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1239 1240 1237 1238 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1241 1242 1239 1240 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1286 1287 1284 1285 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1289 1290 1287 1288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1291 1292 1289 1290 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1566 1567 1564 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 481 486 <span type="species:ncbi:9606">human</span>
The cleavage activity does not appear to fulfill a classical proofreading function since entirely telomeric substrates are cleaved (Fig. 1) (20,25). In Euplotes, de novo telomere formation is extremely precise, where all new telomeres start with the sequence 5'-GGGGTTTT-3' (7). We speculated that the preferred substrate for elongation might be one ending with GGGTTA, and predicted that such a substrate might not be cleaved. We assayed (G3T2A)4 and found that RRL-reconstituted human telomerase favored the direct extension pathway leading predominantly to the formation of products >/=25 nt in length (Fig. 3B, lane 9). The generation of shorter products 13 and 19 nt in length derived from the cleavage of 12 and 6 nt from (G3T2A)4 was reduced compared to the generation of shorter products derived from the cleavage of (T2AG3)4 (Fig. 3B, compare lane 8 with lane 9). The sizes of the cleavage-derived products and the chain termination products generated when substituting dATP with ddATP or TTP with ddTTP were consistent with the potential alignments of the (G3T2A)4 with the RNA template (Fig. 3A), and a nucleolytic cleavage activity that occurs 3' to the A residue. We also found that the cleavage of the telomeric primer [(AG3T2)3] was reduced compared to the cleavage of (T2AG3)4 (data not shown). The reduced cleavage of certain telomeric primers may suggest that these primers are preferred elongation substrates. Alternatively, these primers may preferentially align such that their 3' sequences do not extend beyond the 5'-end of the template (Fig. 3A).
###end p 32
###begin title 33
Primer length requirement of the telomerase-mediated cleavage reaction
###end title 33
###begin p 34
###xml 107 118 107 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c12">12</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c15">15</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c31">31</xref>
###xml 453 454 453 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 455 456 455 456 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 459 460 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 464 465 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 466 467 466 467 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 470 471 470 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 475 476 475 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 477 478 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 481 482 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 486 487 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 488 489 488 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 521 522 521 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 523 524 523 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 527 528 527 528 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 595 596 595 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f4">4</xref>
###xml 740 741 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f4">4</xref>
###xml 850 851 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f4">4</xref>
###xml 993 994 993 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f4">4</xref>
###xml 1244 1245 1244 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f4">4</xref>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
Previous studies have shown that the efficient extension of different length oligonucleotides by human and Tetrahymena telomerases is dependent on telomerase assay reaction conditions (12,15,20,31). We determined the primer length requirement of RRL-reconstituted human telomerase- mediated nucleolytic cleavage activity under our standard reaction conditions. We tested primers containing different numbers of the same telomeric repeat permutation: [(G2T2AG)4, (G2T2AG)3, (G2T2AG)2, (G2T2AG)] and primers shorter than (G2T2AG)2 designed by removing one to six nucleotides from the 5'-end (Fig. 4). We found that primer-sized cleavage-derived products could be visualized in telomerase reactions with primers 9 nt in length or longer (Fig. 4, lanes 2-7). Primers 6, 7 and 8 nt in length were weakly elongated under standard reaction conditions (Fig. 4, lanes 9-11). Upon a 3-fold increase in the primer concentration, it was possible to detect primer-sized products with the 8 nt primer (Fig. 4, lane 13). However, under the same reaction conditions, we could not confirm cleavage of the 6 and 7 nt primers due to their less efficient elongation by telomerase and to the altered mobility of the lowest products derived from these primers (Fig. 4, compare lanes 10, 11 with lanes 14, 15).
###end p 34
###begin title 35
Mechanism of telomeric substrate cleavage
###end title 35
###begin p 36
###xml 20 29 20 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.crassus</italic>
###xml 34 46 34 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 711 712 711 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 714 715 714 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 716 717 716 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 847 848 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f5">5</xref>
###xml 861 862 861 862 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 864 865 864 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 866 867 866 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 945 946 945 946 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 948 949 948 949 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 950 951 950 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 952 953 952 953 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 956 957 956 957 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 980 981 980 981 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 983 984 983 984 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 985 986 985 986 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 987 988 987 988 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 990 991 990 991 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1189 1190 1189 1190 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1192 1193 1192 1193 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1194 1195 1194 1195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1196 1197 1196 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1200 1201 1200 1201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1348 1349 1348 1349 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1351 1352 1351 1352 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1353 1354 1353 1354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1355 1356 1355 1356 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1358 1359 1358 1359 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1505 1506 1503 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f5">5</xref>
###xml 1603 1604 1601 1602 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1606 1607 1604 1605 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1608 1609 1606 1607 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1947 1949 1941 1943 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 20 29 <span type="species:ncbi:5936">E.crassus</span>
###xml 34 46 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 142 147 <span type="species:ncbi:9606">human</span>
Characterization of E.crassus and S.cerevisiae telomerases indicates that the primer cleavage proceeds by an endonucleolytic mechanism. Since human telomerase-mediated primer cleavage activity eliminates nucleotides that are complementary to the template residues, it did not seem to use a classical proofreading mechanism. Therefore we were also interested to determine whether the cleavage activity proceeds by an endonucleolytic mechanism. We designed oligonucleotides containing a phosphorothioate group (represented by an asterisk), a nuclease-resistant phosphodiester substitution that replaces an oxygen of the phosphodiester bond with a sulfur group. Primer extension telomerase assays performed with (T2AG3)4 resulted in the removal of 3 and 9 nt, generating cleavage-derived products 22 and 16 nt in length as described previously (Fig. 5, lane 1). (T2AG3)4 was modified to contain a phosphorothioate substitution three nucleotides [(T2AG3)3T2A*G3] or one nucleotide [(T2AG3)3T2AG2*G] from the 3' terminus, respectively. An endonucleolytic cleavage reaction eliminating 3 nt would be affected by the nuclease-resistant substitution located three nucleotides from the 3'-end of (T2AG3)3T2A*G3. However, the endonucleolytic cleavage removing 3 nt should still proceed if the same modification is located one nucleotide from the 3'-end of (T2AG3)3T2AG2*G. Primer cleavage was similarly abolished by the modifications at either position and led to the formation of products >/=28 nt in length (Fig. 5, lanes 2, 3). Cleavage-derived products 16 nt in length generated by the removal of 9 nt from (T2AG3)4 were also inhibited by the modifications at the same positions, suggesting that the cleavage proceeds by an exonucleolytic mechanism. Substitutions of dATP with ddATP or TTP with ddTTP in telomerase assays generated no detectable chain termination products due to the incorporation of ddATP or ddTTP prior to the incorporation of [alpha-32P]dGTP (data not shown). These results were consistent with an inhibition of primer cleavage prior to the elongation.
###end p 36
###begin p 37
###xml 222 223 222 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 225 226 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 227 228 227 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 229 230 229 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 233 234 233 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 235 236 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 238 239 238 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 313 314 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 316 317 316 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 318 319 318 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 320 321 320 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 324 325 324 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 326 327 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 329 330 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 464 465 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 467 468 467 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 469 470 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 471 472 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 475 476 475 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 477 478 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 480 481 480 481 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 623 624 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f5">5</xref>
###xml 771 772 771 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 774 775 774 775 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 776 777 776 777 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 778 779 778 779 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 782 783 782 783 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 790 791 790 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 793 794 793 794 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 795 796 795 796 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 797 798 797 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 801 802 801 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 803 804 803 804 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 806 807 806 807 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
To determine whether the telomerase-mediated cleavage activity proceeds by an exonucleolytic mechanism, we designed an oligonucleotide carrying a phosphorothioate substitution located nine nucleotides from the 3'-end of (T2AG3)2T2A*G3T2AG3. We predicted that the removal of 9 nt but not 3 nt from the 3'-end of (T2AG3)2T2A*G3T2AG3 would be affected by the nuclease-resistant substitution if the cleavage was exonucleolytic. However, the internal modification in (T2AG3)2T2A*G3T2AG3 abolished the cleavage and inhibited the removal of both 9 and 3 nt and the generation of both shorter products 16 and 22 nt in length (Fig. 5, lane 4). If the cleavage activity is exonucleolytic, we might also expect to see products derived from the removal of fewer than 3 nt for both (T2AG3)3T2A*G3 and (T2AG3)2T2A*G3T2AG3 and products derived from the removal of fewer than 9 nt for the latter primer. However, such products were not detected. These results do not confirm that the cleavage mechanism is exonucleolytic. However, they do not support an endonucleolytic mechanism. Our results raise the possibility that cleavages at multiples sites, whether exonucleolytic or endonucleolytic, might not be independent.
###end p 37
###begin title 38
###xml 32 37 <span type="species:ncbi:9606">human</span>
Cleavage activity of endogenous human telomerase
###end title 38
###begin p 39
###xml 106 114 106 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 170 181 170 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c31">31</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c37">37</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c38">38</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f6">6</xref>
###xml 759 760 759 760 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 762 763 762 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 764 765 764 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 772 773 772 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 775 776 775 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 777 778 777 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 941 942 941 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f6">6</xref>
###xml 1025 1026 1025 1026 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1028 1029 1028 1029 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1030 1031 1030 1031 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 351 356 <span type="species:ncbi:9606">human</span>
###xml 739 744 <span type="species:ncbi:9606">human</span>
###xml 1121 1126 <span type="species:ncbi:9606">human</span>
RRL-reconstituted human telomerase functions similarly to endogenous telomerase with respect to the basic in vitro elongation. However, a comparison of RRL-reconstituted Tetrahymena telomerase to endogenous enzyme has revealed some differences, including differences in repeat addition processivity (31,37,38). To identify and characterize endogenous human telomerase-mediated nucleolytic cleavage activity, we performed primer extension assays using native telomerase enzyme partially purified from 293 cell extracts. As shown in Figure 6, endogenous telomerase catalyzed nucleolytic primer cleavage under standard reaction conditions. We tested a series of oligonucleotides that we had characterized for cleavage using RRL-reconstituted human telomerase. (T2AG3)3 and (T2AG3)4 were cleaved and native telomerase generated cleavage-derived products of the same length (16 and 22 nt) as those generated by RRL-reconstituted telomerase (Fig. 6, compare lane 1 with lanes 2, 3). Telomerase reactions were also performed with (T2AG3)4 using different concentrations of dGTP or primer as those we used with RRL-reconstituted human telomerase. The relative amount of cleavage-derived products was not affected (data not shown).
###end p 39
###begin p 40
###xml 78 79 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 94 95 94 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 262 263 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 287 288 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f6">6</xref>
###xml 314 315 312 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 316 317 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 320 321 318 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 328 329 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 330 331 328 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 334 335 332 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 410 411 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f4">4</xref>
###xml 434 435 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f6">6</xref>
###xml 771 772 769 770 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 773 774 771 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 770 775 768 773 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G<sub>3</sub>T<sub>2</sub>A</bold>
###xml 786 787 784 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 788 789 786 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 785 790 783 788 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G<sub>3</sub>T<sub>2</sub>A</bold>
###xml 965 966 963 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f3">3</xref>
###xml 990 991 988 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f6">6</xref>
###xml 1485 1486 1483 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f5">5</xref>
###xml 1508 1509 1506 1507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh546f6">6</xref>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 709 714 <span type="species:ncbi:9606">human</span>
###xml 1044 1049 <span type="species:ncbi:9606">human</span>
###xml 1402 1407 <span type="species:ncbi:9606">human</span>
Similar to our previous results using RRL-reconstituted human telomerase, (TG)8TAG and (G3T2A)4 were not cleaved and the native enzyme favored the direct extension pathway leading to the formation of products >/=20 or 25 nt in length, respectively (compare Fig. 3B, lanes 5, 9 with Fig. 6, lanes 7, 8). However, (G2T2AG)3 and (G2T2AG)4 were also cleaved, but generated only primer-sized products (compare Fig. 4, lanes 2, 3 with Fig. 6, lanes 4, 6). These results differ from those obtained using RRL-reconstituted telomerase enzyme where more than one nucleotide were cleaved from these primers. To determine whether primers containing nontelomeric sequences are also good cleavage substrates for endogenous human telomerase, we performed telomerase reactions with (10-G3T2A-3) or (7-G3T2A-6). Such reactions also generated products at 17 and 14 nt, respectively, corresponding to the cleavage of the nontelomeric sequences (3 or 6 nt) by the enzyme (compare Fig. 3B, lanes 2, 3 with Fig. 6, lanes 14, 15). Lastly, to determine whether native human telomerase mediates telomeric primer cleavage via an endonucleolytic mechanism like other endogenous telomerase enzymes, we performed telomerase reactions with telomeric primers containing phosphorothioate substitutions. Native telomerase generated similar products as the RRL-reconstituted telomerase enzyme with the modified primers, suggesting that human telomerase may mediate cleavage by an exonucleolytic mechanism (compare Fig. 5, lanes 2-4 with Fig. 6, lanes 10-12).
###end p 40
###begin title 41
DISCUSSION
###end title 41
###begin p 42
###xml 339 350 339 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c31">31</xref>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 247 252 <span type="species:ncbi:9606">human</span>
###xml 372 377 <span type="species:ncbi:9606">human</span>
###xml 709 714 <span type="species:ncbi:9606">human</span>
###xml 879 884 <span type="species:ncbi:9606">human</span>
Properties of the nuclease activity described in our studies suggest that the cleavage reaction is dependent on human telomerase and not a nonspecific nuclease. First, our data indicate that the cleavage reactions occurring with RRL-reconstituted human telomerase and native enzyme share some common features. Similar to RRL-reconstituted Tetrahymena telomerase (31), the human TERT and TR expressed in RRL appear sufficient to cleave a primer DNA substrate. Second, end-radiolabeled primers that are incubated with RRL in the absence of telomerase components are neither cleaved nor elongated. Third, the sites of cleavage within the primer DNA substrates are nonrandom, occurring 3' to the A residue in the human telomeric sequence repeat, GGTTAG, and appear to be dependent on the primer alignment with the 5'-end of the template. Lastly, though we did not extensively purify human telomerase from 293 cells, primer cleavage and DNA synthesis appear to be functionally coupled following a partial purification, suggesting that it is either an inherent property of the enzyme or is catalyzed by an associated factor.
###end p 42
###begin title 43
###xml 14 19 <span type="species:ncbi:9606">human</span>
Regulation of human telomerase-mediated cleavage by primer alignments with the RNA template
###end title 43
###begin p 44
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c13">13</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c28">28</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c31">31</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c39">39</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c40">40</xref>
###xml 374 376 374 376 <underline xmlns:xlink="http://www.w3.org/1999/xlink">UC</underline>
###xml 583 584 583 584 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 809 820 809 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 825 834 825 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.crassus</italic>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 981 990 981 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.crassus</italic>
###xml 992 994 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c28">28</xref>
###xml 106 111 <span type="species:ncbi:4932">yeast</span>
###xml 660 665 <span type="species:ncbi:9606">human</span>
###xml 825 834 <span type="species:ncbi:5936">E.crassus</span>
###xml 981 990 <span type="species:ncbi:5936">E.crassus</span>
Our studies indicate that primer-RNA interactions affect cleavage consistent with results of studies with yeast and ciliate telomerase-mediated nuclease activity (13,20,25,28, 31,39,40). The potential alignments of each primer with the RNA template allowed us to propose a potential cleavage site relative to the RNA template, between the U and C in the sequence 3'-AAUCCCAAUC-5'. The pausing pattern generated by the elongation of the cleavage-derived products is consistent with the addition of radiolabeled dGTP at the 5'-end of the template after a cleavage event. A primer [(TG)8TAG] predicted to align at the 3'-end of the RNA template is not cleaved by human telomerase, leading us to propose that primer cleavage is dependent on primer alignment with the RNA template 5'-end. Similar locations in the Tetrahymena and E.crassus telomerase RNA template were reported to dictate cleavage (20,25), though alternate internal sites have also been observed to mediate cleavage in E.crassus (28). Primers would be cleaved when they are aligned at the 5'-end or beyond the 5'-end of the template to ensure that only residues within the RNA template are copied during telomere synthesis.
###end p 44
###begin p 45
###xml 289 297 289 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Euplotes</italic>
###xml 302 313 302 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 361 369 361 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Euplotes</italic>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c27">27</xref>
###xml 183 188 <span type="species:ncbi:9606">human</span>
###xml 374 379 <span type="species:ncbi:4932">yeast</span>
###xml 418 423 <span type="species:ncbi:9606">human</span>
Consistent with the potential alignments of primers with the 5'-end of the template, the proposed cleavage site and a possible proofreading function, RRL-reconstituted and endogenous human telomerase catalyzed the removal of nucleotides that form a mismatch with the template similarly to Euplotes and Tetrahymena telomerase (20,25). Consistent with studies of Euplotes and yeast telomerase, our results indicate that human telomerase mediated cleavage at the junction of the telomeric and nontelomeric sequences (25,27). Thus the removal of mismatched sequences from telomerase substrates is consistent with a proofreading function for telomerase-mediated cleavage and the enzyme's high fidelity to retain only residues that are complementary to the template.
###end p 45
###begin title 46
Role of telomerase-mediated cleavage activity in the generation of preferred substrates
###end title 46
###begin p 47
###xml 33 44 33 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 150 161 150 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 364 365 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 367 368 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 369 370 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 377 378 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 379 380 379 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 383 384 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 673 684 673 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 844 856 844 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 1061 1063 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c24">24</xref>
###xml 1134 1141 1134 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1220 1227 1220 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 1250 1259 1250 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.crassus</italic>
###xml 1346 1348 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c41">41</xref>
###xml 1351 1363 1351 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 1404 1407 1404 1407 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;3</sub>
###xml 1417 1419 1417 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c42">42</xref>
###xml 1626 1627 1626 1627 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1628 1629 1628 1629 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1630 1631 1630 1631 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1798 1800 1798 1800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c43">43</xref>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 844 856 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 1189 1194 <span type="species:ncbi:9606">human</span>
###xml 1250 1259 <span type="species:ncbi:5936">E.crassus</span>
###xml 1351 1363 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 1516 1521 <span type="species:ncbi:9606">human</span>
###xml 1650 1655 <span type="species:ncbi:9606">Human</span>
###xml 1710 1715 <span type="species:ncbi:9606">human</span>
Cleavage of telomeric primers by Tetrahymena telomerase has been reported, but appears to be restricted to the removal of one nucleotide (20). Unlike Tetrahymena telomerase, RRL-reconstituted human telomerase catalyzed the removal of more than one nucleotide from primers containing permutations of 5'-GGTTAG-3'. We proposed above that several alignments of the (T2AG3)4 and (G2T2AG)4 primers could occur relative to the RNA template to generate two or three different sizes of cleavage-derived products, respectively. Some of the shorter products would thus be generated by cleavage of sequences that extend past the 5'-end of the RNA template, as has been documented for Tetrahymena telomerase (20). However, the function for the cleavage of telomeric primers and their cleavage at multiple sites is unclear. Cleavage of telomeric primers by S.cerevisiae telomerase to generate labeled products shorter than the input primer by up to eight nucleotides has also been reported though a function for the cleavage of telomeric substrates has not been determined (24). We propose that a requirement for the cleavage of telomeric primers in vivo might be to generate a preferred substrate for human telomerase. For example, de novo telomere formation in E.crassus is extremely precise, with new telomeres initiating with the sequence 5'-GGGGTTTT-3' (41). S.cerevisiae also initiate telomere formation with TG1-3 repeats (42). As cleavage of the primer ending in 5'-GGGTTA-3' is reduced, we suggest that new telomeres in human chromosomes might initiate with the sequence 5'-GGGTTA-3'. However, cleavage of the telomeric primer (AG3T2)3 was also reduced. Human telomerase can also add different permutations of the human telomeric sequence to primers derived from the chromosome 16 breakpoint sequence (43). Thus the reduced cleavage of certain telomeric primers may not indicate that they are preferred substrates for elongation by telomerase. Alternatively, such primers may preferentially align such that their 3' sequences do not extend beyond the 5'-end of the template.
###end p 47
###begin p 48
###xml 219 228 219 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.crassus</italic>
###xml 233 245 233 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c25">25</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c27">27</xref>
###xml 534 535 534 535 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 537 538 537 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 539 540 539 540 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 541 542 541 542 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 545 546 545 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 547 548 547 548 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 550 551 550 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 999 1000 999 1000 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1002 1003 1002 1003 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1004 1005 1004 1005 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1006 1007 1006 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1010 1011 1010 1011 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1012 1013 1012 1013 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1015 1016 1015 1016 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 219 228 <span type="species:ncbi:5936">E.crassus</span>
###xml 233 245 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 397 402 <span type="species:ncbi:9606">human</span>
Characterization of the human telomerase-dependent nuclease of telomeric substrates revealed that cleavage may occur by an exonucleolytic mechanism. Our findings were somehow unexpected as primer cleavage by endogenous E.crassus and S.cerevisiae telomerases occurs by an endonucleolytic mechanism (25,27). We obtained similar results whether we used RRL-reconstituted or partially purified native human telomerase enzyme. Though our results suggest that cleavage occurs by an exonucleolytic mechanism, our findings using the primer (T2AG3)2T2A*G3T2AG3 were also surprising, as an internal nuclease-resistant modification should not have affected the cleavage that can occur at the 3'-end of the primer. The modification does not appear to alter the primer alignment with the RNA template, since all the modified primers were efficiently elongated by RRL-reconstituted and endogenous telomerases to generate the expected six nucleotide product pausing pattern. However, one possibility may be that (T2AG3)2T2A*G3T2AG3 aligns only with the modification opposite to the 5'-end of the template that dictates cleavage. Another possibility may be that cleavages at the multiple sites are not independent, and abolishing cleavage at the internal site may affect cleavage at the more 3'-terminal site. Alternatively the modified primers may preferentially align at the 3'-end of the template and are not substrates for a cleavage-mediated reaction that is dependent on primer alignment at the RNA template 5'-end. If either of these scenarios are indeed occurring, we must also consider the possibility that such events may be consistent with an endonucleolytic mode of action.
###end p 48
###begin title 49
Difference between RRL-reconstituted telomerase enzyme and native enzyme
###end title 49
###begin p 50
###xml 270 281 270 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c31">31</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c37">37</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c38">38</xref>
###xml 404 405 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 406 407 406 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 410 411 410 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 417 418 417 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 419 420 419 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 423 424 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 542 543 542 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 544 545 544 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 561 572 561 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena</italic>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c20">20</xref>
###xml 1032 1033 1032 1033 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1035 1036 1035 1036 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1037 1038 1037 1038 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1045 1046 1045 1046 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1048 1049 1048 1049 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1050 1051 1050 1051 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1476 1478 1476 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh546c44">44</xref>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 312 317 <span type="species:ncbi:9606">human</span>
###xml 1238 1243 <span type="species:ncbi:9606">human</span>
###xml 1689 1694 <span type="species:ncbi:9606">human</span>
In our study, we found that processivity and cleavage differed between RRL-reconstituted human telomerase and native enzyme. The reconstituted enzyme complex could be lacking required associated regulatory factors and/or be assembled in a different conformation. As for Tetrahymena telomerase, RRL-reconstituted human enzyme was less processive than endogenous telomerase (31,37,38). Using the primers (G2T2AG)3 or (G2T2AG)4, the native enzyme generated mainly primer-sized products, consistent with cleavage of similar substrates ending in G3T2G by endogenous Tetrahymena telomerase (20). These results suggest a preferential binding of these primers at the 5'-end of hTR in the native enzyme, and do not support the alignment of such primers beyond the 5'-end of the template. This is in contrast to the results we obtained using RRL-reconstituted enzyme where cleaved products were consistent with the primers aligning beyond the template 5'-end. Moreover, the relative amount of cleaved versus elongated products derived from (T2AG3)3 and (T2AG3)4 is less for the native enzyme than the RRL-reconstituted enzyme. The cleavage, particularly marked for the RRL-reconstituted complex, may result from a high frequency of stalling by the human telomerase at several positions along the RNA template. We speculate that the nuclease activity may be an error-correcting mechanism or a way of rescuing pause/arrested complexes, which facilitates the elongation of DNA substrates (44). The native enzyme or telomerase-associated factors may more stringently regulate the alignment and binding of DNA substrates with the RNA template. Further studies will be required to better characterize the human telomerase-mediated cleavage activity and the dependence of this activity on the minimal telomerase components (sequence or structure of hTERT or hTR) and/or additional protein components.
###end p 50
###begin title 51
Figures and Tables
###end title 51
###begin p 52
###xml 33 34 33 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 39 40 39 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 112 113 112 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 118 119 118 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 190 191 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 192 193 192 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 201 202 201 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 203 204 203 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 207 208 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 209 210 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 211 212 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 213 214 213 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 843 844 843 844 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 849 850 849 850 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1128 1129 1128 1129 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1131 1132 1131 1132 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1133 1134 1133 1134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1141 1142 1141 1142 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1144 1145 1144 1145 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1146 1147 1146 1147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
 Cleavage of telomeric 3'-ends. (A and B) Potential alignments of various telomeric oligonucleotides (tested in C and D) with the hTR template, before and after translocation. Compared to (G2T2AG)4, (G2T2AG)3G2T2A2G has an extra A predicted to form a mismatch with the RNA template. Italicized letters represent nucleotides added by the telomerase enzyme onto the 3'-end of the primer during the elongation step. The diagram implies that cleavage and nucleotide addition to the RNA template 5'-end precede translocation. P: primer length. ddA and ddT: dideoxyATP and dideoxyTTP. Numbers in A-D represent the lengths of the primers, elongation or chain termination products. The proposed cleavage site is shown by the vertical arrow. Asterisks indicate the positions of the first ddA or ddT incorporated during the DNA primer extension assay. (C and D) DNA primer extension assays were performed with the indicated oligonucleotides using RRL-reconstituted telomerase enzyme. The elongation products were resolved on 8% polyacrylamide-urea gels and subjected to autoradiography. The 3'-end radiolabeled 5'-biotinylated primers, (T2AG3)3 and (T2AG3)4, migrate, respectively, as 19 and 25mers [P(18)+1 and P(24)+1, respectively].
###end p 52
###begin p 53
###xml 74 75 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 265 267 257 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 396 397 384 385 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 621 622 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 624 625 612 613 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 626 627 614 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 634 635 622 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 637 638 625 626 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 639 640 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
 Effects of different parameters on telomerase-mediated primer cleavage. (A) Effect of dGTP concentration on telomerase-mediated cleavage activity. DNA primer extension assays were conducted using different concentrations of dGTP. In addition to 1.25 microM [alpha-32P]dGTP, unlabeled dGTP was added. Lanes 1 and 3 contain no unlabeled dGTP. Lanes 2 and 4 contain 12.5 microM of unlabeled dGTP. (B) Cleavage of a telomeric primer containing a chain terminator (revdT) at the 3'-end. Direct DNA primer extension assays were performed with the indicated oligonucleotides. The 3'-end radiolabeled 5'-biotinylated primers, (T2AG3)3 and (T2AG3)4, migrate, respectively, as 19 and 25mers at the positions indicated by the arrows. ddA and ddT: dideoxyATP and dideoxyTTP. dGTP: deoxyGTP. Numbers in (A) and (B) represent the lengths of the elongation or chain termination products.
###end p 53
###begin p 54
###xml 87 88 87 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 565 566 565 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 658 659 658 659 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 659 660 659 660 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 660 661 660 661 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 661 662 661 662 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 662 663 662 663 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 678 684 678 684 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GGGTTA</bold>
###xml 692 693 692 693 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 693 694 693 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 694 695 694 695 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 695 696 695 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 696 697 696 697 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 709 715 709 715 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GGGTTA</bold>
###xml 834 835 834 835 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 837 838 837 838 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 839 840 839 840 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 847 848 847 848 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 850 851 850 851 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 852 853 852 853 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
 Cleavage is specified by the primer alignment relative to the RNA template sequence. (A) Potential alignments of various oligonucleotides (tested in B) with the hTR template, before and after translocation. Italicized letters represent nucleotides added by the telomerase enzyme onto the 3'-end of the primer during the elongation step. P: primer length. ddA and ddT: dideoxyATP and dideoxyTTP. The proposed cleavage site is shown by the vertical arrow. Asterisks indicate the positions of the first ddA or ddT incorporated during the DNA primer extension assay. (B) Direct DNA primer extension assays were performed with the indicated oligonucleotides. 10-G3T2A-3: CACTATCGAC-GGGTTA-CAT; 7-G3T2A-6: CACTATC-GGGTTA-GATCAT, where the bold nucleotides represent a telomeric cassette. The 3'-end radiolabeled 5'-biotinylated primers, (T2AG3)3 and (T2AG3)4, migrate, respectively, as 19 and 25mers at the positions indicated by the arrows. Numbers in (A) and (B) represent the lengths of the primers, elongation or chain termination products.
###end p 54
###begin p 55
###xml 310 311 310 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 313 314 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 315 316 315 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 323 324 323 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 326 327 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 328 329 328 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
 Primer length requirement of the telomerase-mediated cleavage activity at different primer concentrations. DNA primer extension assays were performed with the indicated oligonucleotides. The elongation products were resolved on 10% polyacrylamide-urea gels. The 3'-end radiolabeled 5'-biotinylated primers, (T2AG3)3 and (T2AG3)4, migrate, respectively, as 19 and 25mers at the positions indicated by the arrows. Numbers represent the lengths of the elongation products.
###end p 55
###begin p 56
###xml 229 230 229 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 232 233 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 234 235 234 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 242 243 242 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 245 246 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 247 248 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 37 42 <span type="species:ncbi:9606">human</span>
 Cleavage of telomeric substrates by human telomerase may proceed by an exonucleolytic mechanism. DNA primer extension assays were performed with the indicated oligonucleotides. The 3'-end radiolabeled 5'-biotinylated primers, (T2AG3)3 and (T2AG3)4, migrate, respectively, as 19 and 25mers at the positions indicated by the arrows. Numbers represent the lengths of the elongation products. The asterisks indicate the positions of the phosphorothioate modifications within the primers.
###end p 56
###begin p 57
###xml 348 349 348 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 351 352 351 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 361 362 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 364 365 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 366 367 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 53 58 <span type="species:ncbi:9606">human</span>
 Telomerase-mediated cleavage activity of endogenous human telomerase. DNA primer extension assays were performed with the indicated oligonucleotides using RRL-reconstituted telomerase enzyme (lanes 1, 5, 9, 13) or enzyme partially purified from 293 cell extracts (lanes 2-4, 6-8, 10-12, 14, 15). The 3'-end radiolabeled 5'-biotinylated primers, (T2AG3)3 and (T2AG3)4, migrate, respectively, as 19 and 25mers at the positions indicated by the arrows. Numbers represent the lengths of the elongation products.
###end p 57
###begin title 58
ACKNOWLEDGEMENTS
###end title 58
###begin p 59
We thank M. A. Cerone, T. J. Moriarty, D. Marie-Egyptienne and M. A. S. Taboski for comments on the manuscript. C.A. is the recipient of a Fonds de la Recherche en Sante du Quebec Chercheur Boursier and a Boehringer Ingelheim (Canada) Inc. Young Investigator Award. S.H. is the recipient of a Faculty of Medicine Internal Studentships of McGill University. This work was supported by grant MOP-14026 from the Canadian Institutes of Health Research (CIHR) to C.A.
###end p 59
###begin title 60
REFERENCES
###end title 60

